Guest Blog: The antidepressant reboxetine: A headdesk moment in science. From Wordnik.com. [Defending Merck's CEO - Matthew Herper - The Medicine Show - Forbes] Reference
Schatzberg A (2000) Clinical efficacy of reboxetine in major depression. From Wordnik.com. [PLoS Medicine: New Articles] Reference
Note that reboxetine was the least efficacious and least-tolerated drug in the meta-analysis. From Wordnik.com. [MedPageToday.com - medical news plus CME for physicians] Reference
Dr. Cipriani said he would not prescribe reboxetine as a first-line treatment in his patients. From Wordnik.com. [MedPageToday.com - medical news plus CME for physicians] Reference
Dr. Cipriani also noted that reboxetine is the only norepinephrine reuptake inhibitor assessed in their review. From Wordnik.com. [MedPageToday.com - medical news plus CME for physicians] Reference
The IQWiG claims the process was "greatly hindered" by Pfizer, which took a "long time" to make available trial data on reboxetine. From Wordnik.com. [CenterWatch Clinical Trials Today Headlines] Reference
The institute's move follows a disagreement with Pfizer concerning unpublished study data about the company's antidepressant reboxetine. From Wordnik.com. [CenterWatch Clinical Trials Today Headlines] Reference
The final evaluation of reboxetine and mirtazapine was only possible after manufacturers disclosed data that had previously been concealed. From Wordnik.com. [Health News from Medical News Today] Reference
Zoloft, Lexapro the Best of Newer Antidepressants paroxetine (Paxil), reboxetine (Edronax / Vestra), sertraline, and venlafaxine (Effexor). From Wordnik.com. [Medlogs - Recent stories] Reference
Sertraline was found to be more effective than duloxetine by 30\%, fluvoxamine (27\%), fluoxetine (25\%), paroxetine (25\%), and reboxetine (85\%). From Wordnik.com. [Medlogs - Recent stories] Reference
The summary of results from published and non-published trials does not provide proof of benefit of reboxetine, whereas the data from the published trials appear to suggest a benefit. From Wordnik.com. [Health News from Medical News Today] Reference
Antidepressant reboxetine, sold for more than a decade in …. From Wordnik.com. [Yahoo! News: Business - Opinion] Reference
Discontinuation of late-stage development for SS-reboxetine (SNRI for fibromyalgia). From Wordnik.com. [StreetInsider.com News Articles] Reference
As the example of reboxetine shows, concealing trial data can lead to patients receiving a drug, for which there is not only no proof of benefit, but which can also cause harm. ". From Wordnik.com. [Health News from Medical News Today] Reference
Vestra reboxetine. From Wordnik.com. [Continuity Used to Matter at Marvel | Comics Should Be Good! @ Comic Book Resources] Reference
33\%, fluoxetine (32\%), fluvoxamine (35\%), paroxetine (30\%), and reboxetine (95\%). From Wordnik.com. [Medlogs - Recent stories] Reference
1.27, 1.22 respectively), and reboxetine (2.03, 1.95, 1.89, 1.85 respectively), the researchers said. From Wordnik.com. [MedPageToday.com - medical news plus CME for physicians] Reference
So the researchers reviewed 117 randomized controlled trials that enrolled 25,928 patients from 1991 through Nov. 30, 2007 and looked at bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, and venlafaxine. From Wordnik.com. [MedPageToday.com - medical news plus CME for physicians] Reference
LearnThatWord and the Open Dictionary of English are programs by LearnThat Foundation, a 501(c)3 nonprofit.
Questions? Feedback? We want to hear from you!
Email us
or click here for instant support.
Copyright © 2005 and after - LearnThat Foundation. Patents pending.